Pneumococcal Disease | List of Frontiers open access articles

Original Research

Published on 29 Sep 2023

Health and economic outcomes of 20-valent pneumococcal conjugate vaccine compared to 15-valent pneumococcal conjugate vaccine strategies for adults in Greece

in Health Economics

George Gourzoulidis
Myrto Barmpouni
Vasiliki Kossyvaki
Jeffrey Vietri
Charalampos Tzanetakos

Frontiers in Public Health

doi 10.3389/fpubh.2023.1229524

5,213 views
15 citations

Original Research

Published on 20 Sep 2021

Effectiveness of 23-Valent Pneumococcal Polysaccharide Vaccine Against Pneumococcal Diseases Among the Elderly Aged 60 Years or Older: A Matched Test Negative Case-Control Study in Shanghai, China

in Infectious Diseases – Surveillance, Prevention and Treatment

Xiaodong Sun
Xiang Guo
Jing Qiu
Genming Zhao
Xinxin Xu
Abram L. Wagner
Hongli Jiang
Zhuoying Huang
Jia Ren
Xiaoying Ma

Frontiers in Public Health

doi 10.3389/fpubh.2021.620531

4,459 views
4 citations

Review

Published on 01 May 2025

Preventing pneumococcal infections in patients with hematological malignancies: a review of evidence and recommendations based on modified Delphi consensus

in Hematologic Malignancies

Tulika Seth
Sameer Melinkeri
Tuphan Kanti Dolai
Jina Bhattacharyya
Neeraj Sidharthan
Prantar Chakrabarti
Chaithanya Malalur
Santosh Taur

Frontiers in Oncology

doi 10.3389/fonc.2025.1546641

4,801 views
2 citations

Review

Published on 30 May 2025

Serotype distribution of invasive and non-invasive pneumococcal disease in adults ≥65 years of age following the introduction of 10- and 13-valent pneumococcal conjugate vaccines in infant national immunization programs: a systematic literature review

in Infectious Diseases: Epidemiology and Prevention

Patricia Izurieta
Dorota Borys

Frontiers in Public Health

doi 10.3389/fpubh.2025.1544331

4,134 views
2 citations

Review

Published on 23 Dec 2020

Sugar-Coated Killer: Serotype 3 Pneumococcal Disease

in Molecular Bacterial Pathogenesis

Jennifer N. Luck
Hervé Tettelin
Carlos J. Orihuela

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2020.613287

31,192 views
126 citations

Original Research

Published on 15 Nov 2018

Serotypes With Low Invasive Potential Are Associated With an Impaired Antibody Response in Invasive Pneumococcal Disease

in Infectious Agents and Disease

Nils Littorin
Fabian Uddén
Jonas Ahl
Fredrik Resman
Hans-Christian Slotved
Simon Athlin
Kristian Riesbeck

Frontiers in Microbiology

doi 10.3389/fmicb.2018.02746

8,554 views
8 citations

Review

Published on 12 May 2022

Pneumococcal Surface Proteins as Virulence Factors, Immunogens, and Conserved Vaccine Targets

in Molecular Bacterial Pathogenesis

Javid Aceil
Fikri Y. Avci

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2022.832254

12,373 views
43 citations

Original Research

Published on 22 Dec 2021

Liposomal Encapsulation of Polysaccharides (LEPS) as an Effective Vaccine Strategy to Protect Aged Hosts Against S. pneumoniae Infection

in Aging and the Immune System

Manmeet Bhalla
Roozbeh Nayerhoda
Essi Y. I. Tchalla
Alexsandra Abamonte
Dongwon Park
Shaunna R. Simmons
Blaine A. Pfeifer
Elsa N. Bou Ghanem

Frontiers in Aging

doi 10.3389/fragi.2021.798868

4,932 views
8 citations

Original Research

Published on 12 Dec 2025

Antibodies against polysaccharide type 3 and pneumococcal proteins demonstrate synergistic protective effect in a highly virulent type 3 invasive disease model in mice

in Vaccines and Molecular Therapeutics

Taylor C. Stevenson
Heidi Burke
Sara E. Roggensack
Anthony Pratt
Aquib Hossain
Pallab Ghosh
Gilles Besin
Yingjie Lu
Fan Zhang
Richard Malley

Frontiers in Immunology

doi 10.3389/fimmu.2025.1707686

1,888 views

Original Research

Published on 07 Oct 2021

Invasive Pneumococcal Disease in Latvia in PCV10 Vaccination Era, 2012–2018

in Pediatric Pulmonology

Larisa Savrasova
Angelika Krumina
Hedija Cupeca
Indra Zeltina
Anita Villerusha
Ilze Grope
Ludmila Viksna
Elina Dimina
Sooria Balasegaram

Frontiers in Pediatrics

doi 10.3389/fped.2021.532489

3,755 views
3 citations

Original Research

Published on 24 Mar 2020

Validation of a Loop-Mediated Isothermal Amplification Assay for Rapid Diagnosis of Invasive Pneumococcal Disease

in Clinical and Diagnostic Microbiology and Immunology

Héctor David de Paz
Pedro Brotons
Cristina Esteva
Carmen Muñoz-Almagro

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2020.00115

7,980 views
16 citations

Original Research

Published on 12 Oct 2021

Rapid Increase of Oral Bacteria in Nasopharyngeal Microbiota After Antibiotic Treatment in Children With Invasive Pneumococcal Disease

in Molecular Bacterial Pathogenesis

Desiree Henares
Muntsa Rocafort
Pedro Brotons
Mariona F. de Sevilla
Alex Mira
Cristian Launes
Raul Cabrera-Rubio
Carmen Muñoz-Almagro

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2021.744727

6,788 views
14 citations

Original Research

Published on 28 Mar 2022

Ficolin-2 Lectin Complement Pathway Mediates Capsule-Specific Innate Immunity Against Invasive Pneumococcal Disease

in Microbial Immunology

Moon H. Nahm
Jigui Yu
Juan J. Calix
Feroze Ganaie

Frontiers in Immunology

doi 10.3389/fimmu.2022.841062

4,196 views
15 citations

Review

Published on 06 Feb 2026

Pre and post introduction of pneumococcal conjugate vaccines in children in Eastern Mediterranean Region and effect on antimicrobial resistance, a narrative review

in Antimicrobials, Resistance and Chemotherapy

Basma M. Saleh
Osama Mere
Seham Elmrayed

Frontiers in Microbiology

doi 10.3389/fmicb.2026.1735082

1,158 views

Perspective

Published on 20 Apr 2021

Related Factors to Streptococcus pneumoniae Invasive Infection and Clinical Manifestations: The Potential Role of Nasopharyngeal Microbiome

in Infectious Diseases – Surveillance, Prevention and Treatment

Beatriz Dietl
Desirée Henares
Lucía Boix-Palop
Carmen Muñoz-Almagro
Javier Garau
Esther Calbo

Frontiers in Medicine

doi 10.3389/fmed.2021.650271

6,178 views
16 citations

Original Research

Published on 10 Dec 2024

Antibiotic susceptibility testing and molecular characterization based on whole-genome sequencing of Streptococcus pneumoniae isolates from pediatric infections at the National Regional Medical Center of Southwest China during the COVID-19 pandemic

in Infectious Diseases: Epidemiology and Prevention

Ziyi Yan
Chenglin Miao
Li Liu
Yunhan Fu
Xingxin Liu
Hong Li
Linghan Kuang
Yali Cui
Yongmei Jiang

Frontiers in Public Health

doi 10.3389/fpubh.2024.1490401

4,117 views
1 citation

Articles

Health and economic outcomes of 20-valent pneumococcal conjugate vaccine compared to 15-valent pneumococcal conjugate vaccine strategies for adults in Greece

Effectiveness of 23-Valent Pneumococcal Polysaccharide Vaccine Against Pneumococcal Diseases Among the Elderly Aged 60 Years or Older: A Matched Test Negative Case-Control Study in Shanghai, China

Preventing pneumococcal infections in patients with hematological malignancies: a review of evidence and recommendations based on modified Delphi consensus

Serotype distribution of invasive and non-invasive pneumococcal disease in adults ≥65 years of age following the introduction of 10- and 13-valent pneumococcal conjugate vaccines in infant national immunization programs: a systematic literature review

Sugar-Coated Killer: Serotype 3 Pneumococcal Disease

Serotypes With Low Invasive Potential Are Associated With an Impaired Antibody Response in Invasive Pneumococcal Disease

Pneumococcal Surface Proteins as Virulence Factors, Immunogens, and Conserved Vaccine Targets

Liposomal Encapsulation of Polysaccharides (LEPS) as an Effective Vaccine Strategy to Protect Aged Hosts Against S. pneumoniae Infection

Antibodies against polysaccharide type 3 and pneumococcal proteins demonstrate synergistic protective effect in a highly virulent type 3 invasive disease model in mice

Invasive Pneumococcal Disease in Latvia in PCV10 Vaccination Era, 2012–2018

Validation of a Loop-Mediated Isothermal Amplification Assay for Rapid Diagnosis of Invasive Pneumococcal Disease

Rapid Increase of Oral Bacteria in Nasopharyngeal Microbiota After Antibiotic Treatment in Children With Invasive Pneumococcal Disease

Ficolin-2 Lectin Complement Pathway Mediates Capsule-Specific Innate Immunity Against Invasive Pneumococcal Disease

Pre and post introduction of pneumococcal conjugate vaccines in children in Eastern Mediterranean Region and effect on antimicrobial resistance, a narrative review

Related Factors to Streptococcus pneumoniae Invasive Infection and Clinical Manifestations: The Potential Role of Nasopharyngeal Microbiome

Antibiotic susceptibility testing and molecular characterization based on whole-genome sequencing of Streptococcus pneumoniae isolates from pediatric infections at the National Regional Medical Center of Southwest China during the COVID-19 pandemic

Serotype distribution of invasive and non-invasive pneumococcal disease in adults ≥65 years of age following the introduction of 10- and 13-valent pneumococcal conjugate vaccines in infant national immunization programs: a systematic literature review